首页> 外国专利> still for framstellning of new derivatives of 4 - hydroxitiazolidin - 2 -.

still for framstellning of new derivatives of 4 - hydroxitiazolidin - 2 -.

机译:仍用于4-羟噻唑烷新衍生物-2-的新衍生物的缩影。

摘要

4-Hydroxy-3-pyridyl-thiazolidine-2-thiones of formula (I) are new: In the formulae, R1 is opt. branched, 1-4C alkyl in position 4,5, or 6 and R2 is H or opt. branched 1-4C alkyl. The cpds. may be administered orally, rectally or parenterally e.g. orally to adults in daily doses of 50-1000 mg. Typical cpds. are (I) where R1 = 6-methyl. Cpds. where R2 = H or 1-4C primary or secondary alkyl have predominantly structure (A) whilst R2 = t-butyl has predominantly structure (B).
机译:式(I)的4-羟基-3-吡啶基-噻唑烷-2-硫酮是新的:在式中,R 1是优选的。在4,5或6位上有1个支链的1-4C烷基,R 2是H或opt。支链1-4C烷基。 cpds。可以口服,直肠或肠胃外给药,例如成人每日口服剂量为50-1000 mg。典型的cpds。是(I),其中R 1 = 6-甲基。 Cpds。其中R2 = H或1-4C,伯或仲烷基主要具有结构(A),而R2 =叔丁基主要具有结构(B)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号